ArticleZeitschrift fur Rheumatologie2018

Relative efficacy and safety of apremilast, secukinumab, and ustekinumab for the treatment of psoriatic arthritis.

G G Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.